Your browser doesn't support javascript.
loading
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis, Maria-Christina; Vassilakopoulos, Theodoros P; Siakantaris, Marina P; Kokoris, Styliani I; Gribabis, Despina A; Dimopoulou, Maria N; Angelopoulou, Maria K; Pangalis, Gerassimos A.
Affiliation
  • Kyrtsonis MC; Hematology Section and Research Laboratory, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
Eur J Haematol ; 72(4): 252-8, 2004 Apr.
Article in En | MEDLINE | ID: mdl-15089762
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Proteoglycans / Membrane Glycoproteins / Glycoproteins / Biomarkers, Tumor / Fibroblast Growth Factor 2 / Receptors, Cytoplasmic and Nuclear / Multiple Myeloma / Neoplasm Proteins Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2004 Type: Article Affiliation country: Greece
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Proteoglycans / Membrane Glycoproteins / Glycoproteins / Biomarkers, Tumor / Fibroblast Growth Factor 2 / Receptors, Cytoplasmic and Nuclear / Multiple Myeloma / Neoplasm Proteins Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2004 Type: Article Affiliation country: Greece